Salivagram after gland injection of botulinum neurotoxin A in patients with cerebral infarction and cerebral palsy

PM R. 2012 Apr;4(4):312-6. doi: 10.1016/j.pmrj.2011.12.008.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Aged
  • Botulinum Toxins, Type A / administration & dosage*
  • Botulinum Toxins, Type A / therapeutic use
  • Cerebral Infarction / complications*
  • Cerebral Infarction / rehabilitation
  • Cerebral Palsy / complications*
  • Cerebral Palsy / rehabilitation
  • Female
  • Follow-Up Studies
  • Humans
  • Injections, Intralesional
  • Male
  • Neuromuscular Agents / administration & dosage
  • Pneumonia, Aspiration / etiology
  • Pneumonia, Aspiration / prevention & control
  • Radionuclide Imaging
  • Reproducibility of Results
  • Saliva / diagnostic imaging
  • Saliva / metabolism
  • Sialorrhea / complications
  • Sialorrhea / diagnostic imaging
  • Sialorrhea / drug therapy*
  • Sublingual Gland / diagnostic imaging*

Substances

  • Neuromuscular Agents
  • Botulinum Toxins, Type A